All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
On 7th August 2017, in a Letter to the Editor of Acta Neuropathologica Communications, Daniel Kirschenbaum from the Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland, and colleagues reported a case of a male patient, 81 years of age, who presented with intermittent tremor and gait ataxia.
The authors state that this case they report is the first of a fibrin associated DLBCL in an arachnoid cyst with hemorrhage. In rare cases, arachnoid cysts may contain primary or metastatic tumors. In most cases, surgery is often curative; however, the current case was given rituximab and lenalidomide. The authors stress that “greater awareness is important in order to more accurately assess the natural history of this entity.”
Is a response-adapted treatment strategy feasible for patients with MCL?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Mats Jerkeman, Lund University, Lund, SE. We asked, Is a...
NICE recommends lenalidomide in combination with rituximab for patients with previously treated FL
NICE recommend the combination of lenalidomide with rituximab (R2) for adult patients with relapsed or refractory (R/R) FL. The regimen offers a...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox